- Latest week
- 10 Jul 2026
- Close
- 137.500000
- Fair value
- 95.469419
- Next-week expectancy
- Negative 26.27%
U2TH34 Chart Pack
United Therapeutics Corporation
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, U2TH34 fell 10.52%, moving from 153.67 to 137.50. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 1.87 and has softened across the 12-week window. Market Dynamics is -0.96 on the latest week. Next-week expectancy is negative at 26.27% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 137.50
- 12-Week Change
- -10.52%
- Trend Signal
- Active
- Next-Week Expectancy
- Negative 26.27%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- 1.87
- Market Dynamics
- -0.96
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 137.50
- 12-Week Change
- -10.52%
- Trend Signal
- Active
- Next-Week Expectancy
- Negative 26.27%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- 1.87
- Market Dynamics
- -0.96
Over the latest 12 completed weeks ending 2026-07-10, U2TH34 fell 10.52%, moving from 153.67 to 137.50. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 1.87 and has softened across the 12-week window. Market Dynamics is -0.96 on the latest week. Next-week expectancy is negative at 26.27% based on similar historical setup states.
Industry Peers
Brazil equities in Drug Manufacturers - Specialty & Generic
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| BLAU3 Blau Farmacêutica S.A. | SAO | 10 Jul 2026 | 10.11 | 10.63 | 9.92 | 10.55 | 4.35% |
| HYPE3 Hypera S.A. | SAO | 10 Jul 2026 | 20.96 | 21.14 | 20.03 | 21.11 | 0.72% |
| N1BI34 Neurocrine Biosciences, Inc. | SAO | 10 Jul 2026 | 44.90 | 45.78 | 44.90 | 45.05 | 0.33% |
| P1RG34 Perrigo Company plc | SAO | 10 Jul 2026 | 51.74 | 51.74 | 51.74 | 51.74 | 0.00% |
| T1EV34 Teva Pharmaceutical Industries Limited | SAO | 10 Jul 2026 | 89.28 | 89.28 | 89.28 | 89.28 | 0.00% |
| TAKP34 Takeda Pharmaceutical Company Limited | SAO | 10 Jul 2026 | 82.32 | 82.32 | 82.32 | 82.32 | 0.00% |
| Z1TS34 Zoetis Inc. | SAO | 10 Jul 2026 | 24.21 | 24.90 | 23.72 | 24.11 | -0.41% |
| OFSA3 Ouro Fino Saúde Animal Participações S.A. | SAO | 10 Jul 2026 | 28.90 | 29.30 | 26.10 | 27.40 | -5.19% |